Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273325 · ClinicalTrials.gov registry record
Immunogenicity of PCV-7 Vaccine in VLBW Infants
A clinical trial, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- 368
- Enrollment target
NCT00273325 is a clinical trial that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 368 participants.
The verdict
NCT00273325 has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- 368 participants
- Enrollment target
Study Summary
Premature infants are at a high risk for pneumonia. The PCV-7 vaccine effectively prevents the invasive disease from Streptococcus pneumoniae in full-term infants, but was not thoroughly studied in premature infants. This study evaluated the effectiveness and safety of the vaccine given in routine practice to very low birth weight infants, looking at blood antibody levels 4-6 weeks after the final vaccine dose, and adverse events, survival, infections, and neurodevelopmental outcomes at 18-22 months corrected age.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00273325
The ClinicalTrials.gov registry entry for NCT00273325 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00273325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00273325 about?
NCT00273325 is a clinical study titled "Immunogenicity of PCV-7 Vaccine in VLBW Infants". Premature infants are at a high risk for pneumonia. The PCV-7 vaccine effectively prevents the invasive disease from Streptococcus pneumoniae in full-term infants, but was not thoroughly studied in premature infants. This study evaluated the effectiveness and safety of the vaccine given in routine p...
What is the current status of trial NCT00273325?
This trial is currently completed. The enrollment target is 368 participants. The study started on 2004-07. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00273325?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.